Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System
Takashi Komori
Laboratory Investigation (2021) Vol. 102, Iss. 2, pp. 126-133
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know—a minireview
Sverre H. Torp, Ole Solheim, Anne Jarstein Skjulsvik
Acta Neurochirurgica (2022) Vol. 164, Iss. 9, pp. 2453-2464
Open Access | Times Cited: 152
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles
Takashi Komori
Brain Tumor Pathology (2022) Vol. 39, Iss. 2, pp. 47-50
Open Access | Times Cited: 50
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 37
Neuropathologist-level integrated classification of adult-type diffuse gliomas using deep learning from whole-slide pathological images
Weiwei Wang, Yuanshen Zhao, Lianghong Teng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 13
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
Alessio Rizzo, Sara Dall’Armellina, Daniele Antonio Pizzuto, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4039-4039
Open Access | Times Cited: 34
Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment
Rajneesh Mungur, Jie-Sheng Zheng, Ben Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 33
Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
Andrew M. Hersh, Hallie Gaitsch, Safwan Alomari, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3743-3743
Open Access | Times Cited: 30
Long non-coding RNA in glioma: novel genetic players in temozolomide resistance
Jungwook Roh, Mijung Im, JiHoon Kang, et al.
Animal Cells and Systems (2023) Vol. 27, Iss. 1, pp. 19-28
Open Access | Times Cited: 18
Low-Grade Gliomas: Histological Subtypes, Molecular Mechanisms, and Treatment Strategies
Corneliu Toader, Lucian Eva, Daniel Ovidiu Costea, et al.
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1700-1700
Open Access | Times Cited: 16
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock
Nina Nelson, Angela Relógio
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Imply on diagnosis and early prognosis of preoperative [68Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin
Kacper Pełka, Kacper Koczyk, Łukasz Koperski, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Presence of Fragmented Intratumoral Thrombosed Microvasculature in the Necrotic and Peri‐Necrotic Regions on SWI Differentiates IDH Wild‐Type Glioblastoma From IDH Mutant Grade 4 Astrocytoma
Virendra Kumar Yadav, Shalini Sharma, Satyajit Maurya, et al.
Journal of Magnetic Resonance Imaging (2025)
Closed Access
Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
Cristian Ionuț Orășanu, Mariana Aşchie, Mariana Deacu, et al.
Diagnostics (2025) Vol. 15, Iss. 4, pp. 438-438
Open Access
Clinical Impact of a Next-Generation Sequencing Approach for Glioblastoma Patients
Catalina Vivancos Sánchez, María Isabel Esteban Rodríguez, Alberto Peláez‐García, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 744-744
Open Access
Comprehensive analysis of the role of Caspases in glioma
Heming Wang, Qinghua Mei, Pengying Mei
Brain Research (2025), pp. 149529-149529
Closed Access
Understanding Neovascularization in Glioblastoma: Insights from the Current Literature
Mariagiovanna Ballato, Emanuela Germanà, Gabriele Ricciardi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2763-2763
Open Access
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
Elena Tirrò, Michele Massimino, Giuseppe Broggi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
Eric Huang
Biomedicines (2022) Vol. 10, Iss. 2, pp. 246-246
Open Access | Times Cited: 25
Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
Jianing Wu, Abdulrahman Alzahrani, Ozal Beylerli, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation
Aleksandra Sejda, Wiesława Grajkowska, Joanna Trubicka, et al.
Folia Neuropathologica (2022) Vol. 60, Iss. 2, pp. 137-152
Open Access | Times Cited: 24
Adult type diffuse gliomas in the new 2021 WHO Classification
Manila Antonelli, Pietro Luigi Poliani
Pathologica (2022) Vol. 114, Iss. 6, pp. 397-409
Open Access | Times Cited: 24
Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis
Barbara Muoio, Domenico Albano, Francesco Dondi, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1665-1665
Open Access | Times Cited: 22
Rational design of siRNA-based delivery systems for effective treatment of brain diseases
Dailin Lu, Yonghang Sun, Yuxia Luan, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100041-100041
Open Access | Times Cited: 4
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities
Kailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131048-131048
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top